Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Serum Marker LncRNA RP5-977B1 for Differentiating Benign

NCT06531850 is registered in ClinicalTrials.gov with Affiliated Cancer Hospital & Institute of Guangzhou Medical University as lead sponsor.

NCT NCT06531850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06531850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Serum Marker LncRNA RP5-977B1 for Differentiating Benign
Lead sponsor
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2024
Completion date
January 1, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary nodule, tumor of lung